Product correctly added to cart.

discount label
RUFY1 antibody
View 3D

Biosynth logo

RUFY1 antibody

Ref. 3D-70R-20042

50µl
495.00 €
Estimated delivery in United States, on Wednesday 8 Jan 2025

Product Information

Name:
RUFY1 antibody
Description:

The 6-Fluoro-3-indoxyl-beta-D-galactopyranoside is a powerful antituberculosis drug belonging to the class of rifamycins. It is known for its bactericidal activity against tuberculosis infection and has been extensively studied using advanced techniques like transcription-quantitative polymerase chain and patch-clamp technique. This active compound exhibits oxidative metabolites and undergoes hydrolysis by esterases, reduction by glutathione reductase, and oxidation by cytochrome p450 enzymes. It specifically targets Mycobacterium tuberculosis strains and inhibits cell growth in culture.

Tilmicosin is a macrolide antibiotic widely used in veterinary medicine to treat respiratory disorders in animals caused by bacteria such as Clostridium perfringens. By binding to the ribosomal subunit, it effectively inhibits bacterial growth. Additionally, Tilmicosin has shown promising results in reducing tumour necrosis factor-α (TNF

Notice:
Our products are intended for lab use only. For any other use, please contact us.
Brand:
Biosynth
Long term storage:
Notes:

Chemical properties

MDL:
Melting point:
Boiling point:
Flash point:
Density:
Concentration:
EINECS:
Merck:
HS code:

Hazard Info

UN Number:
EQ:
Class:
H Statements:
P Statements:
Forbidden to fly:
Hazard Info:
Packing Group:
LQ:

Technical inquiry about: 3D-70R-20042 RUFY1 antibody

Please use instead the cart to request a quotation or an order

If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.

* Mandatory fields.
Welcome to CymitQuimica!We use cookies to enhance your visit. We do not include advertising.

Please see our Cookies Policy for more details or adjust your preferences in "Settings".